trump glp-1 medicaid announces lower prices for weight-loss drugs, expanded Medicare eligibility The Trump Administration is delivering

This leads us to some bigger questions about who gets access to these drugs and why

Further, many employers (as high as 59% of employers with at least 5,000 workers) that offered such coverage said that use of GLP-1 medications was higher than expected, and 66% of the largest employers said that covering such drugs for weight loss had a significant impact on their health plans prescription drug spending

It's always important to keep in mind as well that prescription medicines have real side effects

Is a GLP-1 Right for Me to Treat Type 2 Diabetes

Product pages and videos lean on phrases like ozempic patch, Wegovy patch, Mounjaro patch, semaglutide patch, and tirzepatide patch, and the branding implies that a prescription drug is crossing your skin

Its a buzzword people are using for the next generation of weight-loss medicines. The injectable GLP-1s like semaglutide and tirzepatide were generation one, says Jobby John, PharmD, founder of Nimbus Healthcare and owner of a pharmacy in Austin, Texas